CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Cytori Therapeutics - PSTV CFD

0.37
2.63%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.06
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.38
Open* 0.38
1-Year Change* -60%
Day's Range* 0.37 - 0.38
52 wk Range 0.28-1.20
Average Volume (10 days) 270.37K
Average Volume (3 months) 6.48M
Market Cap 10.27M
P/E Ratio -100.00K
Shares Outstanding 35.42M
Revenue 224.00K
EPS -0.79
Dividend (Yield %) N/A
Beta 0.42
Next Earnings Date Apr 19, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 23, 2023 0.37 -0.01 -2.63% 0.38 0.38 0.37
Feb 22, 2023 0.38 0.00 0.00% 0.38 0.38 0.38
Feb 8, 2023 0.37 -0.01 -2.63% 0.38 0.38 0.37
Feb 6, 2023 0.38 -0.01 -2.56% 0.39 0.39 0.38
Feb 3, 2023 0.39 0.00 0.00% 0.39 0.39 0.39
Feb 2, 2023 0.39 0.00 0.00% 0.39 0.40 0.38
Feb 1, 2023 0.38 -0.04 -9.52% 0.42 0.42 0.38
Jan 31, 2023 0.40 -0.02 -4.76% 0.42 0.42 0.39
Jan 30, 2023 0.43 0.01 2.38% 0.42 0.44 0.42
Jan 27, 2023 0.42 0.01 2.44% 0.41 0.42 0.40
Jan 26, 2023 0.41 0.00 0.00% 0.41 0.42 0.41
Jan 25, 2023 0.41 0.01 2.50% 0.40 0.42 0.40
Jan 24, 2023 0.41 0.00 0.00% 0.41 0.41 0.41
Jan 23, 2023 0.41 -0.01 -2.38% 0.42 0.43 0.41
Jan 20, 2023 0.41 -0.01 -2.38% 0.42 0.43 0.40
Jan 19, 2023 0.42 0.01 2.44% 0.41 0.42 0.40
Jan 18, 2023 0.42 -0.03 -6.67% 0.45 0.45 0.40
Jan 17, 2023 0.45 0.00 0.00% 0.45 0.45 0.43
Jan 13, 2023 0.45 0.07 18.42% 0.38 0.45 0.38
Jan 9, 2023 0.38 0.00 0.00% 0.38 0.38 0.38

Cytori Therapeutics Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 11.38 6.411 6.654 6.998 0.303 0
Revenue 11.38 6.411 6.654 6.998 0.303 0
Cost of Revenue, Total 2.715 2.543 2.373
Gross Profit 8.665 3.868 4.281
Total Operating Expense 31.086 27.094 19.352 10.655 9.887 12.492
Selling/General/Admin. Expenses, Total 12.174 11.187 8.357 5.29 6.406 6.853
Research & Development 16.197 11.678 8.622 5.365 2.7 5.323
Interest Expense (Income) - Net Operating 0
Unusual Expense (Income) 0 1.686 0 0.781 0.316
Operating Income -19.706 -20.683 -12.698 -3.657 -9.584 -12.492
Interest Income (Expense), Net Non-Operating -2.573 -2.016 0.354 1.607 1.343 -0.907
Other, Net 0.233 0.013 -0.29 -1.233 0
Net Income Before Taxes -22.046 -22.686 -12.634 -3.283 -8.241 -13.399
Net Income After Taxes -22.046 -22.686 -12.634 -3.283 -8.241 -13.399
Net Income Before Extra. Items -22.046 -22.686 -12.634 -3.283 -8.241 -13.399
Net Income -22.046 -22.686 -12.634 -10.887 -8.241 -13.399
Total Adjustments to Net Income 0 -3.977 -2.487 -0.554 0
Income Available to Common Excl. Extra. Items -22.046 -26.663 -15.121 -3.837 -8.241 -13.399
Income Available to Common Incl. Extra. Items -22.046 -26.663 -15.121 -11.441 -8.241 -13.399
Diluted Net Income -22.046 -26.663 -15.121 -11.441 -8.241 -13.399
Diluted Weighted Average Shares 0.03458 0.06478 0.17385 1.38401 4.42784 12.0892
Diluted EPS Excluding Extraordinary Items -637.502 -411.595 -86.9768 -2.77237 -1.86118 -1.10835
Diluted Normalized EPS -637.502 -385.569 -86.9768 -2.77237 -1.6848 -1.08221
Total Extraordinary Items 0 -7.604 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 0 0 0 0 0
Revenue 0 0 0 0
Total Operating Expense 2.479 2.575 3.499 3.939 3.926
Selling/General/Admin. Expenses, Total 1.352 1.469 1.99 2.042 2.141
Research & Development 1.127 1.106 1.491 1.599 1.785
Operating Income -2.479 -2.575 -3.499 -3.939 -3.926
Interest Income (Expense), Net Non-Operating -0.241 -0.225 -0.225 -0.216 -0.19
Net Income Before Taxes -2.72 -2.8 -3.724 -4.155 -4.116
Net Income After Taxes -2.72 -2.8 -3.724 -4.155 -4.116
Net Income Before Extra. Items -2.72 -2.8 -3.724 -4.155 -4.116
Net Income -2.72 -2.8 -3.724 -4.155 -4.116
Income Available to Common Excl. Extra. Items -2.72 -2.8 -3.724 -4.155 -4.116
Income Available to Common Incl. Extra. Items -2.72 -2.8 -3.724 -4.155 -4.116
Diluted Net Income -2.72 -2.8 -3.724 -4.155 -4.116
Diluted Weighted Average Shares 8.2679 11.2968 13.2642 15.4729 21.5071
Diluted EPS Excluding Extraordinary Items -0.32898 -0.24786 -0.28076 -0.26853 -0.19138
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.32898 -0.24786 -0.2794 -0.24927 -0.19138
Unusual Expense (Income) 0 0.018 0.298
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 18.747 14.864 9.648 19.825 9.175 19.724
Cash and Short Term Investments 12.56 9.55 5.261 17.552 8.346 18.4
Cash & Equivalents 12.56 9.55 5.261 17.552 8.346 18.4
Total Receivables, Net 1.242 0.145 0.178 1.313 0
Accounts Receivable - Trade, Net 1.242 0.145 0.178 1.169 0
Total Inventory 3.725 3.183 0.107 0.107 0
Other Current Assets, Total 1.22 1.986 4.102 0.04 0.059 0.007
Total Assets 34.609 31.615 23.991 23.229 12.105 21.981
Property/Plant/Equipment, Total - Net 1.157 3.052 2.299 2.96 2.456 1.818
Goodwill, Net 3.922 3.922 0.372 0.372 0.372 0.372
Intangibles, Net 8.447 7.207 0.086 0.051
Other Long Term Assets, Total 2.336 2.57 11.672 0.072 0.016 0.016
Total Current Liabilities 12.501 18.414 17.559 14.486 8.539 5.87
Payable/Accrued 5.872 4.79 2.777 0.245
Notes Payable/Short Term Debt 6.629 13.624 14.202 0 6.335 1.608
Current Port. of LT Debt/Capital Leases 0 11.18 0.01 0
Total Liabilities 23.623 18.615 18.766 22.069 9.074 11.145
Total Long Term Debt 11.008 0 0 0.008 0 5.005
Long Term Debt 11.008 0 5.005
Other Liabilities, Total 0.114 0.201 1.207 7.575 0.535 0.27
Total Equity 10.986 13 5.225 1.16 3.031 10.836
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.022 0.058 0 0.004 0.007 0.016
Additional Paid-In Capital 388.769 413.304 418.39 426.426 436.535 457.73
Retained Earnings (Accumulated Deficit) -379.063 -401.749 -414.383 -425.27 -433.511 -446.91
Other Equity, Total 1.258 1.387 1.218 0
Total Liabilities & Shareholders’ Equity 34.609 31.615 23.991 23.229 12.105 21.981
Total Common Shares Outstanding 0.04342 0.11565 0.29661 3.88059 6.74903 15.51
Property/Plant/Equipment, Total - Gross 0 3.981 3.843 3.233
Accrued Expenses 0 2.973 1.137 1.529
Other Current Liabilities, Total 0.58 0.006 0.023 0.122
Prepaid Expenses 0.813 0.77 1.317
Accumulated Depreciation, Total -1.021 -1.387 -1.415
Accounts Payable 0.327 0.789 2.611
Capital Lease Obligations 0.008 0
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 15.446 18.001 22.097 19.724 22.104
Cash and Short Term Investments 14.447 17.161 21.28 18.4 21.239
Cash & Equivalents 14.447 17.161 21.28 18.4 21.239
Other Current Assets, Total 0.999 0.84 0.817 1.324 0.865
Total Assets 18.336 20.834 24.75 21.981 24.516
Property/Plant/Equipment, Total - Net 2.425 2.376 2.205 1.818 1.874
Goodwill, Net 0.372 0.372 0.372 0.372 0.372
Intangibles, Net 0.077 0.069 0.06 0.051 0.15
Other Long Term Assets, Total 0.016 0.016 0.016 0.016 0.016
Total Current Liabilities 8.315 8.354 9.488 5.87 4.921
Payable/Accrued 1.713 1.609 2.63 4.151 3.203
Accrued Expenses 0.113 0.127 0.106 0.111 0.11
Notes Payable/Short Term Debt 6.486 6.618 6.752 1.608 1.608
Current Port. of LT Debt/Capital Leases 0.003 0
Total Liabilities 8.823 8.889 9.995 11.145 9.874
Total Long Term Debt 0 0 0 5.005 4.718
Capital Lease Obligations 0
Other Liabilities, Total 0.508 0.535 0.507 0.27 0.235
Total Equity 9.513 11.945 14.755 10.836 14.642
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.01 0.012 0.015 0.016 0.022
Additional Paid-In Capital 445.734 450.964 457.495 457.73 465.646
Retained Earnings (Accumulated Deficit) -436.231 -439.031 -442.755 -446.91 -451.026
Total Liabilities & Shareholders’ Equity 18.336 20.834 24.75 21.981 24.516
Total Common Shares Outstanding 10.1805 12.0875 15.36 15.51 22.1976
Long Term Debt 5.005 4.718
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -22.046 -22.686 -12.634 -10.887 -8.241 -13.399
Cash From Operating Activities -19.533 -18.128 -11.975 -5.906 -8.434 -10.28
Cash From Operating Activities 1.182 2.151 2.004 0.896 0.366 0.395
Non-Cash Items 2.103 3.444 -0.313 5.023 -0.678 1.486
Cash Interest Paid 1.618 1.364 1.331 1.188 0.567 0.388
Changes in Working Capital -0.772 -1.037 -1.032 -0.938 0.119 1.238
Cash From Investing Activities 0.064 -1.383 -0.133 5.57 -0.493 -0.082
Capital Expenditures -0.067 -1.496 -0.133 -0.067 -0.493 -0.144
Other Investing Cash Flow Items, Total 0.131 0.113 0 5.637 0 0.062
Cash From Financing Activities 17.609 16.815 7.168 12.631 -0.319 20.416
Financing Cash Flow Items -3.858 -2.078 -1.598 0
Total Cash Dividends Paid 0
Issuance (Retirement) of Stock, Net 21.467 23.613 8.766 16.454 5.105 20.692
Issuance (Retirement) of Debt, Net 0 -4.72 0 -3.823 -5.424 -0.276
Foreign Exchange Effects 0.082 0.011 0.016 -0.004 0
Net Change in Cash -1.778 -2.685 -4.924 12.291 -9.246 10.054
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -2.72 -5.52 -9.244 -13.399 -4.116
Cash From Operating Activities -3.006 -5.405 -7.656 -10.28 -3.876
Cash From Operating Activities 0.088 0.179 0.266 0.395 0.147
Non-Cash Items 0.257 0.53 0.892 1.486 0.284
Cash Interest Paid 0.096 0.29 0.292 0.388 0.087
Changes in Working Capital -0.631 -0.594 0.43 1.238 -0.191
Cash From Investing Activities -0.084 -0.08 -0.084 -0.082 -0.577
Capital Expenditures -0.084 -0.08 -0.134 -0.144 -0.327
Cash From Financing Activities 9.191 14.3 20.674 20.416 7.292
Issuance (Retirement) of Stock, Net 9.197 14.308 20.682 20.692 7.694
Issuance (Retirement) of Debt, Net -0.006 -0.008 -0.008 -0.276 -0.402
Net Change in Cash 6.101 8.815 12.934 10.054 2.839
Other Investing Cash Flow Items, Total 0.05 0.062 -0.25
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.0859 1092953 385 2022-12-31 LOW
Parkman Healthcare Partners LLC Hedge Fund 1.6474 583467 -741558 2022-12-31 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7286 258052 -385 2022-12-31 LOW
Schonfeld Strategic Advisors LLC Hedge Fund 0.5376 190400 190400 2022-12-31 HIGH
Millennium Management LLC Hedge Fund 0.3865 136903 124500 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2948 104427 0 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 0.2376 84147 -22260 2022-12-31 HIGH
Renaissance Technologies LLC Hedge Fund 0.2213 78370 7470 2022-12-31 HIGH
Petersen (Gregory B) Individual Investor 0.1765 62500 0 2023-02-23 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.0972 34414 0 2022-12-31 LOW
Great Valley Advisor Group, Inc. Investment Advisor 0.0949 33600 0 2022-12-31 LOW
Hedrick (Marc H) Individual Investor 0.0948 33580 0 2023-02-23 LOW
Creative Planning, Inc. Investment Advisor/Hedge Fund 0.0947 33539 0 2022-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.0906 32089 0 2022-12-31 LOW
B. Riley Wealth Advisors, Inc. Investment Advisor 0.0706 25001 25001 2022-12-31 MED
UBS Financial Services, Inc. Investment Advisor 0.0537 19003 2795 2022-12-31 LOW
Clowes (Howard) Individual Investor 0.0508 18000 0 2023-02-23 MED
Virtu Americas LLC Research Firm 0.0385 13647 13647 2022-12-31 HIGH
Sims Andrew (John Hugh MacIntyre) Individual Investor 0.0345 12230 0 2023-02-23 LOW
Warberg Asset Management LLC Hedge Fund 0.0282 10000 0 2022-12-31 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
500000+

Trader

92000+

Klien aktif per bulan

$53000000+

Volume investasi per bulan

$30000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Biotechnology & Medical Research (NEC)

4200 Marathon Blvd Ste 200
78756-3433

Income Statement

  • Annual
  • Quarterly

People also watch

XRP/USD

0.39 Price
-1.210% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00350

Oil - Crude

64.78 Price
-2.720% 1D Chg, %
Biaya inap posisi Long -0.0198%
Biaya inap posisi short -0.0021%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Gold

2,002.12 Price
+0.800% 1D Chg, %
Biaya inap posisi Long -0.0168%
Biaya inap posisi short 0.0086%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

US100

12,425.20 Price
-0.850% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda